Literature DB >> 8448590

A comparison of the inhibitory effects of sodium nitroprusside, pinacidil and nifedipine on pressor response to NG-nitro-L-arginine.

Y X Wang1, T Zhou, C C Pang.   

Abstract

1. The inhibitory effects of sodium nitroprusside (SNP), a nitric oxide (NO) donor, on mean arterial pressure (MAP) responses to NG-nitro-L-arginine (L-NNA) (NO synthase inhibitor), angiotensin II (AII) and noradrenaline (NA) were compared with those of pinacidil (KATP channel opener) and nifedipine (L-type calcium antagonist) in conscious, unrestrained rats. 2. Intravenous bolus injections of L-NNA (1-64 mg kg-1), AII (0.02-1.28 micrograms kg-1) and NA (0.25-16 micrograms kg-1) dose-dependently increased MAP to similar maxima. Intravenous infusions of SNP (1, 4 and 16 micrograms kg-1 min-1) dose-dependently increased ED20S of L-NNA, AII and NA. However, the maximum response evoked by L-NNA, but not by AII nor NA, was dose-dependently reduced by SNP. Moreover, the inhibitory effect of SNP on the pressor response to L-NNA ceased when the infusion of SNP was terminated. 3. Pinacidil (80 micrograms kg-1 min-1 for 30 min followed by 5 micrograms kg-1 min-1) increased ED50S of L-NNA, AII and NA but did not decrease the maximum responses to any of these agents. 4. Nifedipine (1 mg kg-1 min-1) non-selectively reduced maximum responses to L-NNA, AII and NA to similar levels and increased ED50S of AII and NA but not L-NNA. 5. The results show that SNP causes a selective, non-competitive and reversible inhibition of the pressor response to L-NNA. This inhibition by SNP is unlikely to be related to hypotension, the opening of ATP-sensitive potassium channels or blockade of L-type calcium channels.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8448590      PMCID: PMC1907969          DOI: 10.1111/j.1476-5381.1993.tb12816.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

1.  Coronary vasoconstriction in the conscious rabbit following intravenous infusion of L-NG-nitro-arginine.

Authors:  R G Humphries; R D Carr; A K Nicol; W Tomlinson; S E O'Connor
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

2.  L-NG-nitro arginine produces an exaggerated hypertension in anesthetized SHR.

Authors:  P J Lacolley; S J Lewis; M J Brody
Journal:  Eur J Pharmacol       Date:  1991-05-17       Impact factor: 4.432

3.  Effects of sodium nitroprusside on smooth muscle cells of rabbit pulmonary artery and portal vein.

Authors:  Y Ito; H Suzuki; H Kuriyama
Journal:  J Pharmacol Exp Ther       Date:  1978-12       Impact factor: 4.030

4.  Evidence for cyclic GMP-mediated relaxant effects of nitro-compounds in coronary smooth muscle.

Authors:  W R Kukovetz; S Holzmann; A Wurm; G Pöch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

5.  Negative chronotropic effect of a novel class III antiarrhythmic drug, UK-68,798, devoid of beta-blocking action on isolated guinea-pig atria.

Authors:  T Yang; P M Tande; H Refsum
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

6.  Effects of NG-nitro-L-arginine methyl ester on vasodilator responses to acetylcholine, 5'-N-ethylcarboxamidoadenosine or salbutamol in conscious rats.

Authors:  S M Gardiner; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

7.  Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required.

Authors:  J N Bates; M T Baker; R Guerra; D G Harrison
Journal:  Biochem Pharmacol       Date:  1991-12-11       Impact factor: 5.858

8.  Pressor effects of L and D enantiomers of NG-nitro-arginine in conscious rats are antagonized by L- but not D-arginine.

Authors:  Y X Wang; T Zhou; C C Pang
Journal:  Eur J Pharmacol       Date:  1991-07-23       Impact factor: 4.432

9.  Interaction of glyceryl trinitrate and sodium nitroprusside with bovine pulmonary vein homogenate and 10,000 x g supernatant: biotransformation and nitric oxide formation.

Authors:  G S Marks; B E McLaughlin; L B Brown; D E Beaton; B P Booth; K Nakatsu; J F Brien
Journal:  Can J Physiol Pharmacol       Date:  1991-06       Impact factor: 2.273

10.  Actions of nitroglycerine on the membrane and mechanical properties of smooth muscles of the coronary artery of the pig.

Authors:  Y Ito; K Kitamura; H Kuriyama
Journal:  Br J Pharmacol       Date:  1980-10       Impact factor: 8.739

View more
  2 in total

1.  Halothane inhibits the pressor effect of diphenyleneiodonium.

Authors:  Y X Wang; C C Pang
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

2.  Impairment of nitric oxide synthase but not heme oxygenase accounts for baroreflex dysfunction caused by chronic nicotine in female rats.

Authors:  Mohamed A Fouda; Hanan M El-Gowelli; Sahar M El-Gowilly; Laila Rashed; Mahmoud M El-Mas
Journal:  PLoS One       Date:  2014-05-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.